Onesource Specialty Pharma shareholders and shareholding pattern
NSE: ONESOURCEBSE: 544292Pharmaceuticals & BiotechnologySmall Cap
Onesource Specialty Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2025
Last close ₹1,569.60down ₹8.00 (0.51%)BSE ₹1,569.65
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,577.60.
29 Oct: open ₹1,585.00, high ₹1,597.60, low ₹1,564.00
52-week range of traded prices to 29 Oct 2026
₹1,057.00Low, 30 Jan 2026₹1,925.00High, 3 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17,999 Cr373rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.04
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹13 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 0.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,36,95662.9% delivered
Onesource Specialty Pharma's shareholding pattern for Sep 2026, filed on 21 Oct 2026, with every filing from Dec 2024: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Onesource Specialty Pharma, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters30.47%
- Foreign institutions19.46%
- Indian institutions24.21%
- GovernmentsNone
- Individuals and others25.86%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
| Per cent | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| 37.77% | 34.25% | 29.79% | 29.77% | 29.93% | 30.48% | 30.48% | 30.47% | |
| Indian promoters | 37.77% | 34.25% | 29.79% | 29.77% | 29.93% | 30.48% | 30.48% | 30.47% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 62.23% | 65.75% | 70.21% | 70.23% | 70.07% | 69.52% | 69.52% | 69.53% |
| Promoter shares pledgedShare of the promoters' own shares | 9.58% | 20.06% | 25.01% | 26.04% | 18.52% | 38.38% | 37.23% | 38.79% |
| Shares in issue | 11,44,36,021 | 11,44,36,021 | 11,44,66,021 | 11,45,25,216 | 11,45,85,136 | 11,46,21,201 | 11,46,45,801 | 11,46,73,791 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 1,24,64,661 | 3,75,08,854 | 3,67,35,099 | 3,67,34,315 | 3,67,34,315 | 93,78,312 | 93,78,312 | 93,78,312 |
| Promoters' shares locked in | 1,24,64,661 | 1,24,64,661 | 1,16,90,906 | 1,16,90,906 | 1,16,90,906 | 93,78,312 | 93,78,312 | 93,78,312 |
Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Onesource Specialty Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is TENSHI PHARMACEUTICALS PRIVATE LIMITED, 18.39%.Promoter buying and selling
| Holder | ||||
|---|---|---|---|---|
| TENSHI PHARMACEUTICALS PRIVATE LIMITEDIndian companies, trusts and others | 18.39% | 2,10,89,714 | 48.65% | 18.14% |
| KARUNA BUSINESS SOLUTIONS LLPIndian companies, trusts and others | 7.06% | 80,90,353 | 31.35% | 68.65% |
| PRONOMZ VENTURES LLPIndian companies, trusts and others | 2.41% | 27,61,308 | 7.50% | 0.00% |
| ARCO LAB PRIVATE LIMITEDIndian companies, trusts and others | 1.60% | 18,39,900 | 0.00% | 0.00% |
| Arun Kumar PillaiIndividuals and Hindu undivided families | 0.85% | 9,70,497 | 56.67% | 0.00% |
| Vineetha Mohanakumar PillaiIndividuals and Hindu undivided families | 0.04% | 47,500 | 0.00% | 0.00% |
| Padmakumar Karunakaran PillaiIndividuals and Hindu undivided families | 0.04% | 43,242 | 0.00% | 0.00% |
| Aditya Arun KumarIndividuals and Hindu undivided families | 0.03% | 29,211 | 0.00% | 0.00% |
| Rajitha GopalakrishnanIndividuals and Hindu undivided families | 0.03% | 30,000 | 0.00% | 0.00% |
| Sajitha PillaiIndividuals and Hindu undivided families | 0.03% | 35,000 | 0.00% | 0.00% |
| Hemalatha PillaiIndividuals and Hindu undivided families | 0.00% | 3,380 | 0.00% | 0.00% |
Pledged is the share of the holder's own shares pledged to a lender. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Onesource Specialty Pharma, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Onesource Specialty Pharma
| Holder | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITEDCompanies | – | 5.20% | 5.16% | 5.16% | 4.96% | 4.95% |
| SBI LIFE INSURANCE CO. LTDInsurance companies | 1.40% | 1.50% | 1.82% | 2.53% | 2.06% | 2.89% |
| ROUTE ONE OFFSHORE MASTER FUND L.P.Foreign portfolio investors, category I | 2.33% | 2.33% | 2.32% | 2.32% | 2.32% | 2.32% |
| ROUTE ONE FUND I, L.P.Foreign portfolio investors, category I | 2.07% | 2.07% | 2.07% | 2.07% | 2.07% | 2.07% |
| THINK INVESTMENTS PCCForeign companies | – | 2.01% | 1.79% | 1.79% | 1.79% | 1.79% |
| FIDELITY SECURITIES FUND: FIDELITY BLUE CHIP GROWTH FUNDForeign portfolio investors, category I | – | – | – | – | 1.76% | 1.76% |
| 360 ONE SPECIAL OPPORTUNITIES FUND - SERIES 12Alternative investment funds | 1.62% | 1.62% | 1.62% | 1.62% | 1.62% | 1.62% |
| AMANSA HOLDINGS PRIVATE LIMITEDForeign portfolio investors, category I | 3.31% | 3.31% | 3.01% | 3.47% | 1.86% | 1.58% |
| TIMF HOLDINGSForeign companies | – | 2.20% | 2.20% | 2.20% | 1.26% | 1.05% |
| SMALLCAP WORLD FUND, INCForeign portfolio investors, category I | 1.36% | 1.36% | 1.14% | – | – | – |
| MUKUL MAHAVIR AGRAWALResident individuals, over ₹2 lakh at face value | – | 1.05% | 1.05% | – | – | – |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDForeign portfolio investors, category I | – | – | 1.01% | – | – | – |
| NOVA GLOBAL OPPORTUNITIES FUND PCC - TOUCHSTONEForeign companies | – | 1.26% | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Foreign institutions: AMANSA HOLDINGS PRIVATE LIMITED 1.58%, −0.28 pts
- Indian institutions: SBI LIFE INSURANCE CO. LTD 2.89%, +0.83 pts
- Individuals and others: TIMF HOLDINGS 1.05%, −0.21 pts; AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITED 4.95%, −0.01 pts